E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/17/2020 in the Prospect News Structured Products Daily.

New Issue: Citigroup prices $1.01 million contingent coupon autocallables on three stocks

By Sarah Lizee

Olympia, Wash., Aug. 17 – Citigroup Global Markets Holdings Inc. priced $1.01 million of autocallable contingent coupon equity-linked securities due Aug. 12, 2024 linked to the least performing of the common stocks of Bristol-Myers Squibb Co., Gilead Sciences, Inc. and Pfizer Inc., according to a 424B2 filing with the Securities and Exchange Commission.

The notes pay a contingent quarterly coupon at the rate of 8% per year if the least-performing stock closes at or above its coupon barrier value, 55% of its initial share price, on the valuation date for that period.

The notes will be automatically called at par plus the coupon if the least-performing stock closes at or above its initial price on any quarterly autocall date after one year.

The payout at maturity will be par unless the least-performing stock finishes below its final barrier value, 55% of its initial share price, in which case investors will be exposed to the decline of the least performing stock.

The notes are guaranteed by Citigroup Inc.

Citigroup Global Markets Inc. is the underwriter.

Issuer:Citigroup Global Markets Holdings Inc.
Guarantor:Citigroup Inc.
Issue:Autocallable contingent coupon equity-linked securities
Underlying stocks:Bristol-Myers Squibb Co., Gilead Sciences, Inc. and Pfizer Inc.
Amount:$1,011,000
Maturity:Aug. 12, 2024
Coupon:8% per year, payable each quarter if least-performing stock closes at or above coupon barrier value on valuation date for that period
Price:Par
Payout at maturity:Par unless least-performing stock finishes below final barrier value, in which case investors will be exposed to the decline of the least performing stock
Call:Automatically at par if least-performing stock closes at or above initial share price on any quarterly valuation date after one year
Initial share prices:$59.69 for Bristol, $69.00 for Gilead, $38.45 for Pfizer
Coupon/final barriers:$32.83 for Bristol, $37.95 for Gilead, $21.148 for Pfizer, or 55% of initial share prices
Pricing date:Aug. 5
Settlement date:Aug. 12
Underwriter:Citigroup Global Markets Inc.
Fees:2%
Cusip:17328WH27

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.